SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
AMIX

Autonomix Medical, Inc. (NASDAQ:AMIX)

US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
$0.89-$0.15 (-14.32%)
 
Market cap
$484K
Insider Score
Health Score
Analyst consensus
Listed since
Jan 29, 2024
Market Cap$484.14K-96.1%
Revenue (ttm)$0
Net Income-$11.78M+29.4%
EPS-$20.09+81.6%
Shares Out543.30K
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume220,177
Open$1.02
Previous Close$1.04
Day's Range$0.88 - $1.02
52-Week Range$0.88 - $24.68
Betan/a
AnalystsBuy
Price Targetn/a
Earnings DateFeb 10, 2027
-15.38% (1D)
No price history available.

About AMIX

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.

Address
21 Waterway Avenue, The Woodlands, TX, 77380, US
Market Cap
0 million
Employees
10
Industrial Classification
Medical - Devices
Financial Health Score
Fair
From AMIX’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
-14.32%
5 Days
-33.00%
1 Month
-64.36%
6 Months
-89.37%
1 Year
-96.11%

$AMIX stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in AMIX holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by AMIX's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

AMIX Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New AMIX patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to AMIX from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from AMIX’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
No data yet
—
Analyst Ratings
62% of score
60
News & Sentiment
38% of score
72

News check: Autonomix received new US patent for proprietary catheter-based sensing technology and highlighted renal denervation strategy at major medical conference.

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.